CHAIR
:
SPEAKER
(S):
James Toupin, General Counsel, U.S. Patent & Trademark Office
Philip Johnson, Esq, Chief Patent Counsel, Johnson & Johnson
Hans Sauer, PhD, Esq, Associate General Counsel for Intellectual Property, Biotechnology Industry Organization
Tom Feeney, Minority Deputy Ranking Member, Subcommittee on Courts, the Internet, and Intellectual Property, U.S House of Representatives
Description
Past panels on patent legislation affecting the biotechnology industry have included Chairman Smith and Rep. Lofgren of the House IP Subcommittee. For 2007, Rep. Feeney has been invited to join us to discuss the status of sweeping patent-reform legislation before Congress and how the change in House and Senate leadership could affect patent-reform initiatives.
Objectives:
Educate the audience on key patent-reform bills and legislative initiatives that affect the biotechnology and pharmaceutical industries.
Give session participants an opportunity to hear directly from some of the elected officials or their staff most intimately acquainted with patent legislation.
Spur BIO members to get involved by contacting their own representatives to educate lawmakers on these issues.